Related Experiment Video
Updated: May 3, 2026
Culturing Microglia from the Neonatal and Adult Central Nervous System
Published on: August 9, 2013
IL-10 and Cdc42 modulate astrocyte-mediated microglia activation in methamphetamine-induced neuroinflammation
Ana Isabel Silva1,2,3, Renato Socodato4, Carolina Pinto1,2
1Addiction Biology Group, i3S-Instituto de Investigação e Inovação em Saúde, Porto, Portugal.
Abstract:
Methamphetamine (Meth) use is known to induce complex neuroinflammatory responses, particularly involving astrocytes and microglia. Building upon our previous research, which demonstrated that Meth stimulates astrocytes to release tumor necrosis factor (TNF) and glutamate, leading to microglial activation, this study investigates the role of the anti-inflammatory cytokine interleukin-10 (IL-10) in this process. Our findings reveal that the presence of recombinant IL-10 (rIL-10) counteracts Meth-induced excessive glutamate release in astrocyte cultures, which significantly reduces microglial activation. This reduction is associated with the modulation of astrocytic intracellular calcium (Ca2+) dynamics, particularly by restricting the release of Ca2+ from the endoplasmic reticulum to the cytoplasm. Furthermore, we identify the small Rho GTPase Cdc42 as a crucial intermediary in the astrocyte-to-microglia communication pathway under Meth exposure. By employing a transgenic mouse model that overexpresses IL-10 (pMT-10), we also demonstrate in vivo that IL-10 prevents Meth-induced neuroinflammation. These findings not only enhance our understanding of Meth-related neuroinflammatory mechanisms, but also suggest IL-10 and Cdc42 as putative therapeutic targets for treating Meth-induced neuroinflammation.
Insights
Interleukin-10 (IL-10) reduces methamphetamine-induced neuroinflammation by decreasing astrocyte glutamate release and modulating calcium signaling. This highlights IL-10 and Cdc42 as potential therapeutic targets for methamphetamine use disorder.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Methamphetamine (Meth) use triggers neuroinflammation involving astrocytes and microglia.
- Previous work showed Meth stimulates astrocytes to release tumor necrosis factor (TNF) and glutamate, activating microglia.
Purpose of the Study:
- Investigate the role of interleukin-10 (IL-10) in Meth-induced neuroinflammation.
- Determine if IL-10 can mitigate Meth's effects on astrocyte-microglia communication.
Main Methods:
- Utilized astrocyte cultures treated with Meth and recombinant IL-10 (rIL-10).
- Assessed astrocytic glutamate release, intracellular calcium (Ca2+) dynamics, and microglial activation.
- Employed a transgenic mouse model overexpressing IL-10 (pMT-10) for in vivo studies.
- Investigated the involvement of the Rho GTPase Cdc42.
Main Results:
- rIL-10 counteracted Meth-induced glutamate release from astrocytes, reducing microglial activation.
- IL-10 modulated astrocytic Ca2+ dynamics, limiting endoplasmic reticulum to cytoplasm release.
- Cdc42 was identified as a key mediator in astrocyte-microglia communication under Meth exposure.
- In vivo studies confirmed IL-10 prevents Meth-induced neuroinflammation.
Conclusions:
- IL-10 effectively reduces Meth-induced neuroinflammation by targeting astrocyte-mediated signaling.
- Cdc42 plays a critical role in the communication pathway between astrocytes and microglia during Meth exposure.
- IL-10 and Cdc42 represent promising therapeutic targets for mitigating Meth-induced neuroinflammation.
